Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Galega G 4mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Edoc Life Sciences Pvt Ltd

Salt Composition

Glimepiride (4mg) + Metformin (500mg)

Overview Galega G 4mg/500mg Tablet

Diabetic medication, Glucobal 4mg/500mg tablets, is classified as an antidiabetic agent. This dual-action formulation treats type 2 diabetes in adults, effectively managing blood glucose. Glucobal should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. The most prevalent adverse effect of Glucobal is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms—sweating, dizziness, headache, trembling—and appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be minimized. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is a possibility for some patients. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Consult your physician before using Glucobal if pregnant or breastfeeding. Regular blood glucose monitoring is necessary; additional blood tests to assess blood cell counts and liver function may be recommended by your doctor.

Primary Ingredients of Galega G 4mg/500mg Tablet

The provided text is "undefined," offering no content to rephrase.

Uses of Galega G 4mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Galega G 4mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 4mg/500mg Galega G Tablet whole; do not crush, chew, or break it. Administer this medication with food.

Common Side effects of Galega G 4mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Galega G 4mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Galega G 4mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Galega G 4mg/500mg Tablet works:

Each Galega G 4mg/500mg tablet contains glimepiride (4mg) and metformin (500mg), two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Galega G 4mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Galega G 4mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against these risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Administration of Galega G 4mg/500mg tablets is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harmful effects to the nursing infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Galega G 4mg/500mg tablets, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Galega G 4mg/500mg tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Galega G 4mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation with a low dose is typical; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Galega G 4mg/500mg Tablet :

Should you forget a Galega G 4mg/500mg Tablet dose, take it immediately if you remember. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Galega G 4mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Galega G 4mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Galega G 4mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Galega G 4mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Galega G 4mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Galega G 4mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake is recommended at least annually, according to some researchers.
Galega G 4mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Galega G 4mg/500mg Tablet with alcohol is unsafe. Alcohol can exacerbate the tablet's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Galega G 4mg/500mg Tablet
89
MRP 108
17% off